Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382158 · ClinicalTrials.gov registry record
International PPB/DICER1 Registry
A clinical trial of Wilms Tumor and Pineoblastoma, sponsored by Children's Hospitals and Clinics of Minnesota.
- Recruiting
- Registry status
- 3,400
- Enrollment target
- 1
- Study location
NCT03382158 is a study of Wilms Tumor and Pineoblastoma that is actively recruiting participants, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 3,400 participants, above the 50-participant average among 14 other Wilms Tumor trials with a reported enrollment target (6700% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03382158, a study of Wilms Tumor and Pineoblastoma, is actively recruiting participants, sponsored by Children's Hospitals and Clinics of Minnesota.
- RECRUITING
- Registry status
- 3,400 participants
- Enrollment target
- 1
- Study location
Study Summary
Pleuropulmonary blastoma (PPB) is a rare malignant neoplasm of the lung presenting in early childhood. Type I PPB is a purely cystic lesion, Type II is a partially cystic, partially solid tumor, Type III is a completely solid tumor. Treatment of children with PPB is at the discretion of the treating institution. This study builds off of the 2009 study and will also seek to enroll individuals with DICER1-associated conditions, some of whom may present only with the DICER1 gene mutation, which will help the Registry understand how these tumors and conditions develop, their clinical course and the most effective treatments.
Conditions Studied
Study Locations (1)
Minnesota
- Children's Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,400 participants |
| Start Date | 2016-12-06 |
| Est. Completion | 2035-12-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03382158
The ClinicalTrials.gov registry entry for NCT03382158 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50-participant average among 14 other Wilms Tumor trials with a reported enrollment target (6700% higher). The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Wilms Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT03382158 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03382158 about?
NCT03382158 is a clinical study titled "International PPB/DICER1 Registry". Pleuropulmonary blastoma (PPB) is a rare malignant neoplasm of the lung presenting in early childhood. Type I PPB is a purely cystic lesion, Type II is a partially cystic, partially solid tumor, Type III is a completely solid tumor. Treatment of children with PPB is at the discretion of the treating...
What is the current status of trial NCT03382158?
This trial is currently recruiting. The enrollment target is 3,400 participants. The study started on 2016-12-06. Estimated completion is 2035-12-06.
What conditions does trial NCT03382158 study?
This clinical trial studies the following conditions: Wilms Tumor, Pineoblastoma, Pleuropulmonary Blastoma, DICER1 Syndrome, Cystic Nephroma.
Who is sponsoring clinical trial NCT03382158?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382158 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wilms Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pencil Beam Scanning in Patients With Renal Tumors
RECRUITING · Early Phase 1
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
RECRUITING · Phase 1
-
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RECRUITING · Phase 1
-
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.